Suppr超能文献

移动卒中单元:证据、差距和下一步。

Mobile Stroke Units: Evidence, Gaps, and Next Steps.

机构信息

Department of Neurology and Brain and Mind Research Institute, Weill Cornell Medicine and NewYork-Presbyterian Hospital' New York (B.B.N.).

Department of Neurology, Center for Stroke Research, Charite-Universitatsmedizin, Berlin, Germany (H.J.A.).

出版信息

Stroke. 2022 Jun;53(6):2103-2113. doi: 10.1161/STROKEAHA.121.037376. Epub 2022 Mar 25.

Abstract

Mobile stroke units (MSUs) are specialized ambulances equipped with the personnel, equipment, and imaging capability to diagnose and treat acute stroke in the prehospital setting. Over the past decade, MSUs have proliferated throughout the world, particularly in European and US cities, culminating in the formation of an international consortium. Randomized trials have demonstrated that MSUs increase stroke thrombolysis rates and reduce onset-to-treatment times but until recently it was uncertain if these advantages would translate into better patient outcomes. In 2021, 2 pivotal, large, controlled clinical trials, B_PROUD and BEST-MSU, demonstrated that as compared with conventional emergency care, treatment aboard MSUs was safe and led to improved functional outcomes in patients with stroke. Further, the observed benefit of MSUs appeared to be primarily driven by the higher frequency of ultra-early thrombolysis within the golden hour. Nevertheless, questions remain regarding the cost-effectiveness of MSUs, their utility in nonurban settings, and optimal infrastructure. In addition, in much of the world, MSUs are currently not reimbursed by insurers nor accepted as standard care by regulatory bodies. As MSUs are now established as one of the few proven acute stroke interventions with an effect size that is comparable to that of intravenous thrombolysis and stroke units, stroke leaders and organizations should work with emergency medical services, governments, and community stakeholders to determine how MSUs might benefit individual communities, and their optimal organization and financing. Future research to explore the effect of MSUs on intracranial hemorrhage and thrombectomy outcomes, cost-effectiveness, and novel models including the use of rendezvous transports, helicopters, and advanced neuroimaging is ongoing. Recommended next steps for MSUs include reimbursement by insurers, integration with ambulance networks, recognition by program accreditors, and inclusion in registries that monitor care quality.

摘要

移动卒中单元(MSU)是配备有人员、设备和成像能力的专业救护车,可在院前环境中诊断和治疗急性卒中。在过去的十年中,MSU 在全球范围内迅速普及,尤其是在欧洲和美国的城市,最终形成了一个国际联盟。随机试验表明,MSU 提高了卒中溶栓率并缩短了发病至治疗的时间,但直到最近,人们还不确定这些优势是否会转化为更好的患者结局。2021 年,两项重要的、大型的对照临床试验 B_PROUD 和 BEST-MSU 表明,与常规急诊护理相比,MSU 上的治疗是安全的,并可改善卒中患者的功能结局。此外,观察到的 MSU 益处似乎主要是由于在黄金时间内超早期溶栓的频率更高所致。然而,关于 MSU 的成本效益、在非城市环境中的实用性以及最佳基础设施等问题仍有待解决。此外,在世界上的许多地方,MSU 目前尚未得到保险公司的报销,也未被监管机构作为标准护理接受。由于 MSU 现在已被确立为为数不多的几种经证实的急性卒中干预措施之一,其效果大小与静脉溶栓和卒中单元相当,因此卒中领导者和组织应与紧急医疗服务、政府和社区利益相关者合作,以确定 MSU 如何使各个社区受益,以及它们的最佳组织和融资方式。目前正在进行关于 MSU 对颅内出血和取栓结局、成本效益以及包括会合转运、直升机和先进神经影像学在内的新型模型的影响的研究。下一步建议包括保险公司报销、与救护车网络整合、计划认证机构认可以及纳入监测护理质量的登记处。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验